The global Genome Editing and Genome Engineering market size was valued at US$ million in 2023. With growing demand in downstream market, the Genome Editing and Genome Engineering is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Genome Editing and Genome Engineering market. Genome Editing and Genome Engineering are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Genome Editing and Genome Engineering. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Genome Editing and Genome Engineering market.
Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.
Key Features:
The report on Genome Editing and Genome Engineering market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Genome Editing and Genome Engineering market. It may include historical data, market segmentation by Type (e.g., CRISPR, TALEN), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Genome Editing and Genome Engineering market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Genome Editing and Genome Engineering market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Genome Editing and Genome Engineering industry. This include advancements in Genome Editing and Genome Engineering technology, Genome Editing and Genome Engineering new entrants, Genome Editing and Genome Engineering new investment, and other innovations that are shaping the future of Genome Editing and Genome Engineering.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Genome Editing and Genome Engineering market. It includes factors influencing customer ' purchasing decisions, preferences for Genome Editing and Genome Engineering product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Genome Editing and Genome Engineering market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Genome Editing and Genome Engineering market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Genome Editing and Genome Engineering market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Genome Editing and Genome Engineering industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Genome Editing and Genome Engineering market.
麻豆原创 Segmentation:
Genome Editing and Genome Engineering market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
CRISPR
TALEN
ZFN
Segmentation by application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Genome Editing and Genome Engineering 麻豆原创 Size 2019-2030
2.1.2 Genome Editing and Genome Engineering 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Genome Editing and Genome Engineering Segment by Type
2.2.1 CRISPR
2.2.2 TALEN
2.2.3 ZFN
2.3 Genome Editing and Genome Engineering 麻豆原创 Size by Type
2.3.1 Genome Editing and Genome Engineering 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Genome Editing and Genome Engineering 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Genome Editing and Genome Engineering Segment by Application
2.4.1 Cell Line Engineering
2.4.2 Animal Genetic Engineering
2.4.3 Plant Genetic Engineering
2.4.4 Others
2.5 Genome Editing and Genome Engineering 麻豆原创 Size by Application
2.5.1 Genome Editing and Genome Engineering 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Genome Editing and Genome Engineering 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Genome Editing and Genome Engineering 麻豆原创 Size by Player
3.1 Genome Editing and Genome Engineering 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Genome Editing and Genome Engineering Revenue by Players (2019-2024)
3.1.2 Global Genome Editing and Genome Engineering Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Genome Editing and Genome Engineering Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Genome Editing and Genome Engineering by Regions
4.1 Genome Editing and Genome Engineering 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Genome Editing and Genome Engineering 麻豆原创 Size Growth (2019-2024)
4.3 APAC Genome Editing and Genome Engineering 麻豆原创 Size Growth (2019-2024)
4.4 Europe Genome Editing and Genome Engineering 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Genome Editing and Genome Engineering 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Genome Editing and Genome Engineering 麻豆原创 Size by Country (2019-2024)
5.2 Americas Genome Editing and Genome Engineering 麻豆原创 Size by Type (2019-2024)
5.3 Americas Genome Editing and Genome Engineering 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genome Editing and Genome Engineering 麻豆原创 Size by Region (2019-2024)
6.2 APAC Genome Editing and Genome Engineering 麻豆原创 Size by Type (2019-2024)
6.3 APAC Genome Editing and Genome Engineering 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Genome Editing and Genome Engineering by Country (2019-2024)
7.2 Europe Genome Editing and Genome Engineering 麻豆原创 Size by Type (2019-2024)
7.3 Europe Genome Editing and Genome Engineering 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genome Editing and Genome Engineering by Region (2019-2024)
8.2 Middle East & Africa Genome Editing and Genome Engineering 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Genome Editing and Genome Engineering 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Genome Editing and Genome Engineering 麻豆原创 Forecast
10.1 Global Genome Editing and Genome Engineering Forecast by Regions (2025-2030)
10.1.1 Global Genome Editing and Genome Engineering Forecast by Regions (2025-2030)
10.1.2 Americas Genome Editing and Genome Engineering Forecast
10.1.3 APAC Genome Editing and Genome Engineering Forecast
10.1.4 Europe Genome Editing and Genome Engineering Forecast
10.1.5 Middle East & Africa Genome Editing and Genome Engineering Forecast
10.2 Americas Genome Editing and Genome Engineering Forecast by Country (2025-2030)
10.2.1 United States Genome Editing and Genome Engineering 麻豆原创 Forecast
10.2.2 Canada Genome Editing and Genome Engineering 麻豆原创 Forecast
10.2.3 Mexico Genome Editing and Genome Engineering 麻豆原创 Forecast
10.2.4 Brazil Genome Editing and Genome Engineering 麻豆原创 Forecast
10.3 APAC Genome Editing and Genome Engineering Forecast by Region (2025-2030)
10.3.1 China Genome Editing and Genome Engineering 麻豆原创 Forecast
10.3.2 Japan Genome Editing and Genome Engineering 麻豆原创 Forecast
10.3.3 Korea Genome Editing and Genome Engineering 麻豆原创 Forecast
10.3.4 Southeast Asia Genome Editing and Genome Engineering 麻豆原创 Forecast
10.3.5 India Genome Editing and Genome Engineering 麻豆原创 Forecast
10.3.6 Australia Genome Editing and Genome Engineering 麻豆原创 Forecast
10.4 Europe Genome Editing and Genome Engineering Forecast by Country (2025-2030)
10.4.1 Germany Genome Editing and Genome Engineering 麻豆原创 Forecast
10.4.2 France Genome Editing and Genome Engineering 麻豆原创 Forecast
10.4.3 UK Genome Editing and Genome Engineering 麻豆原创 Forecast
10.4.4 Italy Genome Editing and Genome Engineering 麻豆原创 Forecast
10.4.5 Russia Genome Editing and Genome Engineering 麻豆原创 Forecast
10.5 Middle East & Africa Genome Editing and Genome Engineering Forecast by Region (2025-2030)
10.5.1 Egypt Genome Editing and Genome Engineering 麻豆原创 Forecast
10.5.2 South Africa Genome Editing and Genome Engineering 麻豆原创 Forecast
10.5.3 Israel Genome Editing and Genome Engineering 麻豆原创 Forecast
10.5.4 Turkey Genome Editing and Genome Engineering 麻豆原创 Forecast
10.5.5 GCC Countries Genome Editing and Genome Engineering 麻豆原创 Forecast
10.6 Global Genome Editing and Genome Engineering Forecast by Type (2025-2030)
10.7 Global Genome Editing and Genome Engineering Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Genome Editing and Genome Engineering Product Offered
11.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Genome Editing and Genome Engineering Product Offered
11.2.3 Merck Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Information
11.3.2 Horizon Discovery Genome Editing and Genome Engineering Product Offered
11.3.3 Horizon Discovery Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Horizon Discovery Main Business Overview
11.3.5 Horizon Discovery Latest Developments
11.4 Genscript
11.4.1 Genscript Company Information
11.4.2 Genscript Genome Editing and Genome Engineering Product Offered
11.4.3 Genscript Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Genscript Main Business Overview
11.4.5 Genscript Latest Developments
11.5 Sangamo Biosciences
11.5.1 Sangamo Biosciences Company Information
11.5.2 Sangamo Biosciences Genome Editing and Genome Engineering Product Offered
11.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Sangamo Biosciences Main Business Overview
11.5.5 Sangamo Biosciences Latest Developments
11.6 Integrated DNA Technologies
11.6.1 Integrated DNA Technologies Company Information
11.6.2 Integrated DNA Technologies Genome Editing and Genome Engineering Product Offered
11.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Integrated DNA Technologies Main Business Overview
11.6.5 Integrated DNA Technologies Latest Developments
11.7 Lonza
11.7.1 Lonza Company Information
11.7.2 Lonza Genome Editing and Genome Engineering Product Offered
11.7.3 Lonza Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Lonza Main Business Overview
11.7.5 Lonza Latest Developments
11.8 New England Biolabs
11.8.1 New England Biolabs Company Information
11.8.2 New England Biolabs Genome Editing and Genome Engineering Product Offered
11.8.3 New England Biolabs Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 New England Biolabs Main Business Overview
11.8.5 New England Biolabs Latest Developments
11.9 Origene Technologies
11.9.1 Origene Technologies Company Information
11.9.2 Origene Technologies Genome Editing and Genome Engineering Product Offered
11.9.3 Origene Technologies Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Origene Technologies Main Business Overview
11.9.5 Origene Technologies Latest Developments
11.10 Transposagen Biopharmaceuticals
11.10.1 Transposagen Biopharmaceuticals Company Information
11.10.2 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product Offered
11.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Transposagen Biopharmaceuticals Main Business Overview
11.10.5 Transposagen Biopharmaceuticals Latest Developments
11.11 Editas Medicine
11.11.1 Editas Medicine Company Information
11.11.2 Editas Medicine Genome Editing and Genome Engineering Product Offered
11.11.3 Editas Medicine Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Editas Medicine Main Business Overview
11.11.5 Editas Medicine Latest Developments
11.12 Crispr Therapeutics
11.12.1 Crispr Therapeutics Company Information
11.12.2 Crispr Therapeutics Genome Editing and Genome Engineering Product Offered
11.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Crispr Therapeutics Main Business Overview
11.12.5 Crispr Therapeutics Latest Developments
11.13 Tecan Life Sciences
11.13.1 Tecan Life Sciences Company Information
11.13.2 Tecan Life Sciences Genome Editing and Genome Engineering Product Offered
11.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Tecan Life Sciences Main Business Overview
11.13.5 Tecan Life Sciences Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
